| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA349354
Max Phase: Preclinical
Molecular Formula: C10H10N4O2
Molecular Weight: 218.22
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccc(Nc2nc(=O)[nH]c(=O)[nH]2)cc1
Standard InChI: InChI=1S/C10H10N4O2/c1-6-2-4-7(5-3-6)11-8-12-9(15)14-10(16)13-8/h2-5H,1H3,(H3,11,12,13,14,15,16)
Standard InChI Key: URMZCOHWOALSKM-UHFFFAOYSA-N
Associated Targets(non-human)
DNA topoisomerase III 145 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 218.22 | Molecular Weight (Monoisotopic): 218.0804 | AlogP: 0.51 | #Rotatable Bonds: 2 |
| Polar Surface Area: 90.64 | Molecular Species: ACID | HBA: 4 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 5.16 | CX Basic pKa: 0.80 | CX LogP: 1.28 | CX LogD: -0.50 |
| Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.68 | Np Likeness Score: -1.20 |
References
| 1. Trantolo DJ, Wright GE, Brown NC.. (1986) Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines., 29 (5): [PMID:3084785] [10.1021/jm00155a016] |
Source
Source(1):